There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K35/28
Subcategories
This category has the following 5 subcategories, out of 5 total.
D
G
S
Y
Pages in category "A61K35/28"
The following 26 pages are in this category, out of 26 total.
1
- 18007439. GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18208490. LUTEINIZING HORMONE RECEPTOR BINDING AGENTS AND LUTEINIZING HORMONE AGONISTS TO IDENTIFY, EXPAND, ABLATE AND MODIFY STEM CELLS simplified abstract (Fred Hutchinson Cancer Center)
- 18273716. METHODS FOR TREATING AND AMELIORATING CANCER simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18410502. QUALITY MANAGEMENT METHOD FOR CELL AND METHOD OF PRODUCING CELL simplified abstract (FUJIFILM Corporation)
- 18412092. QUALITY MANAGEMENT METHOD FOR SPECIFIC CELL AND METHOD OF PRODUCING SPECIFIC CELL simplified abstract (FUJIFILM CORPORATION)
- 18463631. PRODUCTION METHOD FOR THERAPEUTIC AGENT FOR ARTHROSIS, AND THERAPEUTIC AGENT FOR ARTHROSIS simplified abstract (FUJIFILM Corporation)
- 18551975. GENE CORRECTION FOR RAG2 DEFICIENCY IN HUMAN STEM CELLS simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18558802. UROLITHIN FOR INCREASING STEM CELL FUNCTION simplified abstract (SOCIETE DES PRODUITS NESTLE S.A.)
- 18590366. THERAPEUTIC AGENT FOR ARTHROSIS AND PRODUCTION METHOD FOR THERAPEUTIC AGENT FOR ARTHROSIS simplified abstract (FUJIFILM Corporation)
- 18658077. METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract (The Regents of the University of California)
- 18658138. METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract (The Regents of the University of California)
- 18694962. USE OF HUMAN MESENCHYMAL STEM CELL SHEET IN TREATMENT OF UTERINE SCARS (BOE Technology Group Co., Ltd.)
- 18832890. BASE EDITING AND CRISPR/CAS9 GENE EDITING STRATEGIES TO CORRECT CD3 SEVERE COMBINED IMMUNODEFICIENCY IN HEMATOPOIETIC STEM CELLS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
2
- 20240024344. Methods For The Effective Treatment Of Metastatic Cancer simplified abstract (General Oncology, Inc.)
- 20240024362. DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 20240024363. TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT simplified abstract (CREATIVE MEDICAL TECHNOLOGIES, INC.)
B
F
T
- The regents of the university of california (20240293578). METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract
- The regents of the university of california (20240301017). METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract
- The regents of the university of california (20250144147). BASE EDITING AND CRISPR/CAS9 GENE EDITING STRATEGIES TO CORRECT CD3 SEVERE COMBINED IMMUNODEFICIENCY IN HEMATOPOIETIC STEM CELLS
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on May 8th, 2025
- The Regents of the University of California patent applications on September 12th, 2024
- The Regents of the University of California patent applications on September 5th, 2024